Showing results (121-130 of 250) with videos related to

Sort By:
Pageof 25
Plos One|September 23, 2016
Correction: Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood CulturesAlexia Verroken, Lydwine Defourny, Olivier le Polain de Waroux, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 29, 2010
Prolonged paradoxical response to anti-tuberculous treatment after infliximabSara Melboucy-Belkhir, Gabriella Flexor, Jérôme Stirnemann, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 2, 2020
Absence of SARS-CoV-2 in the effluent of peritoneal dialysis patientsAlexandre Candellier, Anaïs Scohy, Nicolas Gillet, et al.
Infectious Diseases Now|September 14, 2024
Impact of [18F] FDG PET/CT on outcomes in patients with Staphylococcus aureus bacteremia: A retrospective single-center experienceSébastien Briol, Olivier Gheysens, François Jamar, et al.
Natural Product Research|June 28, 2013
Antimicrobial activity and evolution of the composition of essential oil from Algerian Anacyclus pyrethrum L. through the vegetative cycleChaouki Selles, Mohammed El Amine Dib, Nassim Djabou, et al.
Case Reports in Oncology|February 6, 2023
High Response Rate to Carboplatin-Paclitaxel-Cetuximab and Pembrolizumab in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaBruno Chauffert, Yuedan Zhou, Liza Medjkoune, et al.
Rheumatology (Oxford, England)|December 22, 2017
Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infectionJulien Henry, Jacques-Eric Gottenberg, Stéphanie Rouanet, et al.
Rheumatology (Oxford, England)|October 16, 2019
Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapyAlice Combier, Gaétane Nocturne, Julien Henry, et al.
Journal of Medical Virology|August 16, 2020
Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID-19 patientsReza Soleimani, Mehdi Khourssaji, Damien Gruson, et al.
Scientific Reports|May 11, 2018
Impact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patientsLeïla Belkhir, Carole Seguin-Devaux, Laure Elens, et al.
Pageof 25